Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis
Sponsors
Anhui Provincial Hospital
Conditions
Autoimmune DiseasesLymphoblastic LeukemiaRelapsed or Refractory Multiple Myeloma (RRMM)
Unknown Phase
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
RecruitingNCT06961669
Start: 2025-04-16End: 2028-08-31Target: 18Updated: 2025-05-29
CAR-T Cells Therapy for Patients With Autoimmune Diseases
RecruitingNCT07052565
Start: 2025-07-20End: 2028-11-01Target: 18Updated: 2025-07-08